Correction to: Effect of CYP3A Inhibition and Induction on the Pharmacokinetics of Suvorexant: Two Phase I, Open-Label, Fixed-Sequence Trials in Healthy Subjects

Clin Drug Investig. 2019 May;39(5):453-454. doi: 10.1007/s40261-019-00777-6.

Abstract

The original version of this article unfortunately contained a mistake.

Publication types

  • Published Erratum